Mahmoud El Iskandarani, Reshma Golamari, Branco G M Bettinotti, Elias Akiki, Daniela Urina Jassir, Tarec K Elajami, Francine K Welty, Esteban Escolar, Christos G Mihos
{"title":"肺动脉高压患者妊娠:一项系统回顾和meta回归分析。","authors":"Mahmoud El Iskandarani, Reshma Golamari, Branco G M Bettinotti, Elias Akiki, Daniela Urina Jassir, Tarec K Elajami, Francine K Welty, Esteban Escolar, Christos G Mihos","doi":"10.21037/jtd-2025-430","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Pregnancy in patients with significant pulmonary hypertension (PH) is a contraindication due to high maternal and fetal mortality. However, recent data shows that an increasing number of women with PH are successfully carrying pregnancies to term, likely because of advancements in multidisciplinary care and treatment. This systematic review and meta-analysis aims to evaluate recent outcomes and identify risk factors associated with morbidity and mortality in this high-risk group.</p><p><strong>Methods: </strong>An unrestricted search was conducted across MEDLINE, EMBASE, and Cochrane databases for studies on outcomes in pregnant patients with PH from inception until May 30, 2024. For one-group analyses, event rates and 95% confidence interval (CI) were calculated using a random-effects model. Meta-regression was performed with Comprehensive Meta-Analysis version 4, employing covariates in logistic regression models. For two-group comparisons, odd ratios (ORs) and 95% CIs were calculated using Review Manager version 5.4 utilizing a random-effects model.</p><p><strong>Results: </strong>Fifty-one studies involving 4,583 pregnant patients with PH were included. The maternal mortality rate was 7.6% (95% CI: 5.8-9.9%). Most deaths (93%) occurred in the postpartum period. Severe PH was associated with a significantly higher rate of maternal mortality compared to mild/moderate PH with OR 5.57 (95% CI: 3.12-9.94). Higher systolic pulmonary artery pressure (sPAP) was associated with a higher mortality rate with a regression coefficient of 0.96. Similarly, the presence of Eisenmenger syndrome (ES) was linked to a higher mortality rate with a regression coefficient of 1. Severe PH was also associated with higher rates of abortion (OR =3.64, 95% CI: 2.61-5.09), prematurity (OR =2.52, 95% CI: 1.66-3.81), and small gestational age (OR =3.96, 95% CI: 2.96-5.29) compared with mild/moderate PH.</p><p><strong>Conclusions: </strong>Although the outcomes of pregnant patients with PH continue to improve, severe PH continues to be associated with a high mortality rate, abortion rate, prematurity, and small gestational age. Our findings support the existing consensus against pregnancy in severe PH and emphasize the need for thorough, individualized discussions about risks for patients with mild/moderate PH.</p>","PeriodicalId":17542,"journal":{"name":"Journal of thoracic disease","volume":"17 7","pages":"5108-5121"},"PeriodicalIF":1.9000,"publicationDate":"2025-07-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12340376/pdf/","citationCount":"0","resultStr":"{\"title\":\"Pregnancy in patients with pulmonary hypertension: a systematic review and meta-analysis with meta-regression.\",\"authors\":\"Mahmoud El Iskandarani, Reshma Golamari, Branco G M Bettinotti, Elias Akiki, Daniela Urina Jassir, Tarec K Elajami, Francine K Welty, Esteban Escolar, Christos G Mihos\",\"doi\":\"10.21037/jtd-2025-430\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Pregnancy in patients with significant pulmonary hypertension (PH) is a contraindication due to high maternal and fetal mortality. However, recent data shows that an increasing number of women with PH are successfully carrying pregnancies to term, likely because of advancements in multidisciplinary care and treatment. This systematic review and meta-analysis aims to evaluate recent outcomes and identify risk factors associated with morbidity and mortality in this high-risk group.</p><p><strong>Methods: </strong>An unrestricted search was conducted across MEDLINE, EMBASE, and Cochrane databases for studies on outcomes in pregnant patients with PH from inception until May 30, 2024. For one-group analyses, event rates and 95% confidence interval (CI) were calculated using a random-effects model. Meta-regression was performed with Comprehensive Meta-Analysis version 4, employing covariates in logistic regression models. For two-group comparisons, odd ratios (ORs) and 95% CIs were calculated using Review Manager version 5.4 utilizing a random-effects model.</p><p><strong>Results: </strong>Fifty-one studies involving 4,583 pregnant patients with PH were included. The maternal mortality rate was 7.6% (95% CI: 5.8-9.9%). Most deaths (93%) occurred in the postpartum period. Severe PH was associated with a significantly higher rate of maternal mortality compared to mild/moderate PH with OR 5.57 (95% CI: 3.12-9.94). Higher systolic pulmonary artery pressure (sPAP) was associated with a higher mortality rate with a regression coefficient of 0.96. Similarly, the presence of Eisenmenger syndrome (ES) was linked to a higher mortality rate with a regression coefficient of 1. Severe PH was also associated with higher rates of abortion (OR =3.64, 95% CI: 2.61-5.09), prematurity (OR =2.52, 95% CI: 1.66-3.81), and small gestational age (OR =3.96, 95% CI: 2.96-5.29) compared with mild/moderate PH.</p><p><strong>Conclusions: </strong>Although the outcomes of pregnant patients with PH continue to improve, severe PH continues to be associated with a high mortality rate, abortion rate, prematurity, and small gestational age. Our findings support the existing consensus against pregnancy in severe PH and emphasize the need for thorough, individualized discussions about risks for patients with mild/moderate PH.</p>\",\"PeriodicalId\":17542,\"journal\":{\"name\":\"Journal of thoracic disease\",\"volume\":\"17 7\",\"pages\":\"5108-5121\"},\"PeriodicalIF\":1.9000,\"publicationDate\":\"2025-07-31\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12340376/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of thoracic disease\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.21037/jtd-2025-430\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/7/28 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q3\",\"JCRName\":\"RESPIRATORY SYSTEM\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of thoracic disease","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.21037/jtd-2025-430","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/7/28 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"RESPIRATORY SYSTEM","Score":null,"Total":0}
Pregnancy in patients with pulmonary hypertension: a systematic review and meta-analysis with meta-regression.
Background: Pregnancy in patients with significant pulmonary hypertension (PH) is a contraindication due to high maternal and fetal mortality. However, recent data shows that an increasing number of women with PH are successfully carrying pregnancies to term, likely because of advancements in multidisciplinary care and treatment. This systematic review and meta-analysis aims to evaluate recent outcomes and identify risk factors associated with morbidity and mortality in this high-risk group.
Methods: An unrestricted search was conducted across MEDLINE, EMBASE, and Cochrane databases for studies on outcomes in pregnant patients with PH from inception until May 30, 2024. For one-group analyses, event rates and 95% confidence interval (CI) were calculated using a random-effects model. Meta-regression was performed with Comprehensive Meta-Analysis version 4, employing covariates in logistic regression models. For two-group comparisons, odd ratios (ORs) and 95% CIs were calculated using Review Manager version 5.4 utilizing a random-effects model.
Results: Fifty-one studies involving 4,583 pregnant patients with PH were included. The maternal mortality rate was 7.6% (95% CI: 5.8-9.9%). Most deaths (93%) occurred in the postpartum period. Severe PH was associated with a significantly higher rate of maternal mortality compared to mild/moderate PH with OR 5.57 (95% CI: 3.12-9.94). Higher systolic pulmonary artery pressure (sPAP) was associated with a higher mortality rate with a regression coefficient of 0.96. Similarly, the presence of Eisenmenger syndrome (ES) was linked to a higher mortality rate with a regression coefficient of 1. Severe PH was also associated with higher rates of abortion (OR =3.64, 95% CI: 2.61-5.09), prematurity (OR =2.52, 95% CI: 1.66-3.81), and small gestational age (OR =3.96, 95% CI: 2.96-5.29) compared with mild/moderate PH.
Conclusions: Although the outcomes of pregnant patients with PH continue to improve, severe PH continues to be associated with a high mortality rate, abortion rate, prematurity, and small gestational age. Our findings support the existing consensus against pregnancy in severe PH and emphasize the need for thorough, individualized discussions about risks for patients with mild/moderate PH.
期刊介绍:
The Journal of Thoracic Disease (JTD, J Thorac Dis, pISSN: 2072-1439; eISSN: 2077-6624) was founded in Dec 2009, and indexed in PubMed in Dec 2011 and Science Citation Index SCI in Feb 2013. It is published quarterly (Dec 2009- Dec 2011), bimonthly (Jan 2012 - Dec 2013), monthly (Jan. 2014-) and openly distributed worldwide. JTD received its impact factor of 2.365 for the year 2016. JTD publishes manuscripts that describe new findings and provide current, practical information on the diagnosis and treatment of conditions related to thoracic disease. All the submission and reviewing are conducted electronically so that rapid review is assured.